home / stock / pgnx / pgnx quote
Last: | $4.10 |
---|---|
Change Percent: | -9.39% |
Open: | $4.6 |
Close: | $4.10 |
High: | $4.79 |
Low: | $3.94 |
Volume: | 34,341,608 |
Last Trade Date Time: | 06/19/2020 04:55:36 pm |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$4.1 | $4.6 | $4.1 | $4.79 | $3.94 | 34,341,608 | 06-19-2020 |
$4.525 | $4.23 | $4.525 | $4.59 | $4.23 | 3,174,990 | 06-18-2020 |
$4.33 | $4.4 | $4.33 | $4.45 | $4.2 | 1,870,517 | 06-17-2020 |
$4.4 | $4.43 | $4.4 | $4.58 | $4.3 | 955,005 | 06-16-2020 |
$4.19 | $3.92 | $4.19 | $4.22 | $3.8644 | 618,043 | 06-15-2020 |
$4.13 | $4.16 | $4.13 | $4.22 | $4.11 | 104,988 | 06-11-2020 |
$4.38 | $4.65 | $4.38 | $4.65 | $4.31 | 602,759 | 06-10-2020 |
$4.62 | $4.68 | $4.62 | $4.77 | $4.565 | 398,073 | 06-09-2020 |
$4.8 | $4.59 | $4.8 | $4.8301 | $4.56 | 597,187 | 06-08-2020 |
$4.515 | $4.55 | $4.515 | $4.77 | $4.425 | 617,324 | 06-05-2020 |
$4.46 | $4.27 | $4.46 | $4.55 | $4.2 | 476,417 | 06-04-2020 |
$4.35 | $4.4 | $4.35 | $4.5 | $4.32 | 419,631 | 06-03-2020 |
$4.31 | $4.3 | $4.31 | $4.38 | $4.18 | 432,277 | 06-02-2020 |
$4.24 | $4.26 | $4.24 | $4.43 | $4.18 | 656,926 | 06-01-2020 |
$4.245 | $4.34 | $4.245 | $4.4 | $4.17 | 623,514 | 05-29-2020 |
$4.36 | $4.42 | $4.36 | $4.51 | $4.24 | 684,159 | 05-28-2020 |
$4.29 | $4 | $4.29 | $4.34 | $3.86 | 707,415 | 05-27-2020 |
$3.94 | $4 | $3.94 | $4.1299 | $3.83 | 807,971 | 05-26-2020 |
$3.96 | $3.95 | $3.96 | $3.96 | $3.77 | 355,399 | 05-25-2020 |
$3.96 | $3.95 | $3.96 | $3.96 | $3.77 | 355,399 | 05-22-2020 |
News, Short Squeeze, Breakout and More Instantly...
Progenics Pharmaceuticals Inc. Company Name:
PGNX Stock Symbol:
NASDAQ Market:
Progenics Pharmaceuticals Inc. Website:
The second half of the year could provide some solid wins for investors in the cancer therapeutics market. In recent years, Wall Street has flocked to many of these biotechnology companies because of their potential to deliver cutting-edge treatments and generate long-term returns. As cancer ...
Biopharma Dynavax Technologies (NASDAQ: DVAX) is one of many companies racing to develop a COVID-19 vaccine. Like many coronavirus-focused companies, Dynavax has seen its shares rise on the ongoing concern related to the pandemic -- in its case, by 50% year to date. While investors may co...
Lantheus Holdings, Inc. (the “Company”) (NASDAQ: LNTH), the parent company of Lantheus Medical Imaging, Inc. (“LMI”), a global leader in the development, manufacture and commercialization of innovative diagnostic imaging agents and products, today announced that it...